"Als modernes Haus der Maximalversorgung bietet das Helios Klinikum Krefeld nahezu das gesamte Leistungsspektrum der Medizin an. Fast 3.000 Mitarbeiter in den verschiedensten Berufsgruppen stellen gemeinsam sicher, dass unsere ambulanten und stationären Patienten rund um die Uhr fachliche und menschlich kompetent betreut werden. Dafür stehen mehr als 30 Fachabteilungen, innovative Medizin-Technologie sowie helle und freundlich ausgestattete Zimmer zur Verfügung."

During the past decade, Klinikum Krefeld GmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Krefeld GmbH" #1 sponsor was "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 4 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored, "Universitätsklinikum Hamburg-Eppendorf" with 2 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Krefeld GmbH" #1 collaborator was "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Krefeld GmbH" are "Leukemia" (4 trials), "Lymphoma" (4 trials), "Neuroblastoma" (3 trials), "Brain and Central Nervous System Tumors" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Klinikum Krefeld GmbH" in a lesser frequency.

Most popular intervention types in "Klinikum Krefeld GmbH" are "Drug" (12 trials), "Radiation" (11 trials), "Biological" (9 trials), "Procedure" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (9 trials), "cyclophosphamide" (8 trials), "doxorubicin hydrochloride" (7 trials), "vincristine sulfate" (7 trials) and "filgrastim" (6 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Krefeld GmbH" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Krefeld GmbH". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Klinikum Krefeld GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Krefeld GmbH, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Klinikum Krefeld GmbH has several departments that took part in Clinical trials: "ZAGO-Zentrum für ambulante gynäkologische Onkologie" - 3 trials, "Klinik für Herzchirurgie Karlsruhe" - 2 trials, "HELIOS Klinikum Krefeld, Zentrum für Kinder- und Jugendmedizin, Päd. Hämatologie/Onkologie" - 2 trials